Short follicular phase following ovarian stimulation with corifollitropin alfa is reported by previous studies as a less frequent, but common event, without impact in reproductive outcomes. However, in my point of view, clinicians seem to be extremely cautious when dominant follicles reach 17 mm diameter without any additional FSH dose after corifollitropin alfa. What do you think? What do you see in your center?

More Bruno Ramalho de Carvalho's questions See All
Similar questions and discussions